Stock Scorecard
Stock Summary for Fennec Pharmaceuticals Inc (FENC) - $9.89 as of 5/29/2026 2:24:10 PM EST
Total Score
9 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for FENC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for FENC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for FENC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for FENC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for FENC (34 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for FENC
Financial Details for FENC
Company Overview |
|
|---|---|
| Ticker | FENC |
| Company Name | Fennec Pharmaceuticals Inc |
| Country | USA |
| Description | Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 9.89 |
| Price 4 Years Ago | 9.60 |
| Last Day Price Updated | 5/29/2026 2:24:10 PM EST |
| Last Day Volume | 1,066,951 |
| Average Daily Volume | 250,435 |
| 52-Week High | 10.45 |
| 52-Week Low | 5.65 |
| Last Price to 52 Week Low | 75.04% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 108.94 |
| Sector PE | 66.00 |
| 5-Year Average PE | 18.49 |
| Free Cash Flow Ratio | 8.53 |
| Industry Free Cash Flow Ratio | 25.30 |
| Sector Free Cash Flow Ratio | 34.59 |
| Current Ratio Most Recent Quarter | 6.98 |
| Total Cash Per Share | 1.16 |
| Book Value Per Share Most Recent Quarter | 1.09 |
| Price to Book Ratio | 9.11 |
| Industry Price to Book Ratio | 15.24 |
| Sector Price to Book Ratio | 23.00 |
| Price to Sales Ratio Twelve Trailing Months | 6.85 |
| Industry Price to Sales Ratio Twelve Trailing Months | 13.16 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.25 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 34,737,000 |
| Market Capitalization | 343,548,930 |
| Institutional Ownership | 54.29% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 1.98% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -2,134.17% |
| Reported EPS 12 Trailing Months | -0.29 |
| Reported EPS Past Year | 0.01 |
| Reported EPS Prior Year | -0.27 |
| Net Income Twelve Trailing Months | -8,376,000 |
| Net Income Past Year | -9,741,000 |
| Net Income Prior Year | -436,000 |
| Quarterly Revenue Growth YOY | 72.60% |
| 5-Year Revenue Growth | 204.69% |
| Operating Margin Twelve Trailing Months | -0.79% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 40,179,000 |
| Total Cash Past Year | 36,721,051 |
| Total Cash Prior Year | 26,634,000 |
| Net Cash Position Most Recent Quarter | 20,802,000 |
| Net Cash Position Past Year | 17,383,051 |
| Long Term Debt Past Year | 19,338,000 |
| Long Term Debt Prior Year | 19,338,000 |
| Total Debt Most Recent Quarter | 19,377,000 |
| Equity to Debt Ratio Past Year | 0.64 |
| Equity to Debt Ratio Most Recent Quarter | 0.66 |
| Total Stockholder Equity Past Year | 35,051,095 |
| Total Stockholder Equity Prior Year | -5,872,000 |
| Total Stockholder Equity Most Recent Quarter | 37,675,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -5,776,002 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.17 |
| Free Cash Flow Past Year | -12,473,000 |
| Free Cash Flow Prior Year | 26,980,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.89 |
| MACD Signal | 0.68 |
| 20-Day Bollinger Lower Band | 5.30 |
| 20-Day Bollinger Middle Band | 7.68 |
| 20-Day Bollinger Upper Band | 10.06 |
| Beta | 0.91 |
| RSI | 72.86 |
| 50-Day SMA | 8.05 |
| 150-Day SMA | 7.57 |
| 200-Day SMA | 7.79 |
System |
|
| Modified | 5/27/2026 10:49:39 PM EST |